{
  "schemaVersion": 1,
  "organisationId": "O-f4d8e47ac7504baaa0f6fd20e9499e86",
  "slug": "alcon",
  "name": "ALCON INC",
  "updatedAt": "2026-03-20T05:05:42.228234Z",
  "sections": [
    {
      "type": "OVERVIEW",
      "text": "Alcon Inc. is a global eye care company operating in healthcare and medical technology, with activities spanning the research, development, manufacture, distribution, and sale of products across two main businesses: Surgical and Vision Care.[P-1a37f89c289c4989882dfce3105753c1][P-01443116eca041228efb337fff6f2f86] Its Surgical business includes implantables, consumables, and equipment used in cataract, vitreoretinal, refractive laser, and glaucoma procedures, while Vision Care includes contact lenses and ocular health products such as treatments and care products for dry eye, ocular allergies, glaucoma, contact lens care, ocular vitamins, and redness relief.[P-36209d85eb704cf0ab44a6c12aa614de][P-e942a20bf9114acc94c97bcf8d4de1a3]\n\nThe company’s stated purpose is to help people “See Brilliantly” by improving lives through innovative eye care.[P-f9caf3f82a674ff0970db5207b84547f][P-85b96b3159244662b7b7721636f51f3d] Alcon reported about $9.4 billion in net sales in 2023, employed more than 25,000 associates, operates directly in 56 countries, and serves consumers and patients in more than 140 countries, reflecting a broad global commercial and operating footprint.[P-1a37f89c289c4989882dfce3105753c1][P-69e31f47af214e529c029b391f2f74be][P-532498a2b25647909bfcc688d79b2d02][P-94fb4af7b9024e1bb5df7d9a1f3bbe86]\n[P-1a37f89c289c4989882dfce3105753c1][P-01443116eca041228efb337fff6f2f86][P-36209d85eb704cf0ab44a6c12aa614de][P-e942a20bf9114acc94c97bcf8d4de1a3][P-f9caf3f82a674ff0970db5207b84547f][P-85b96b3159244662b7b7721636f51f3d][P-69e31f47af214e529c029b391f2f74be][P-532498a2b25647909bfcc688d79b2d02][P-94fb4af7b9024e1bb5df7d9a1f3bbe86]",
      "updatedAt": "2026-03-20T05:05:42.228234Z"
    },
    {
      "type": "PRODUCTS",
      "text": "Alcon’s product portfolio is concentrated in ophthalmic devices and eye-care consumables. In Surgical, it sells implantables, consumables and equipment for cataract, vitreoretinal, refractive laser and glaucoma procedures, and also provides related training, education and technical support.[P-cd41ce9d9526495f952db60ccde56bfc] Its cataract platform includes the Centurion vision system, whose Active Fluidics technology allows surgeons to set and maintain target intraocular pressure during lens removal; the LenSx femtosecond laser for corneal incisions, capsulorhexis and lens fragmentation; the ARGOS biometer based on swept-source OCT; the ORA intra-operative measurement system for IOL alignment; and the Unity CS cataract platform, which the company says delivers phacoemulsification that is 2x faster with 40% less energy.[P-094cdf2a5a16486c94dec8cd630fd277][P-4a918bdc6ce742099f9f774009a3b9a4] Implantable products include the Clareon intraocular lens platform, including monofocal and toric lenses, the Clareon PanOptix trifocal lens for near, intermediate and distance vision, the Clareon Vivity extended-depth-of-focus lens, and preloaded delivery systems such as AutonoMe and UltraSert.[P-094cdf2a5a16486c94dec8cd630fd277][P-1f15f9af2aa2437ba7694297a8d7ad77]\n\nOther surgical products include the Unity VCS vitreoretinal system with Hypervit 30K technology, described as achieving 1.5x faster vitreous cutting rates, the NGENUITY 3D visualization system, and the LuxOR ophthalmic microscope with ILLUMIN-i illumination.[P-a9a0f600fbc142cc817f628021df983e][P-8440ef557ab847278f97f636bb58fdd0][P-094cdf2a5a16486c94dec8cd630fd277] In glaucoma, Alcon markets the Hydrus Microstent, a minimally invasive implant placed in Schlemm’s canal to lower intraocular pressure by enhancing natural outflow, the EX-PRESS Glaucoma Filtration Device, and the Voyager DSLT non-invasive laser treatment platform.[P-22dcda6ecfb340edaaaaad778c0c4da6][P-094cdf2a5a16486c94dec8cd630fd277][P-9d2e22d6015945a28a5c740a4a75ce8c]\n\nIn Vision Care, Alcon sells contact lenses and ocular-health products. Its contact lens lineup includes DAILIES TOTAL1, described as the first and only water-gradient disposable contact lens; TOTAL30, a reusable water-gradient lens; PRECISION1, a daily disposable silicone hydrogel lens with aqueous extraction and surface treatment; PRECISION1 for Astigmatism with the PRECISION BALANCE 8|4 design; DAILIES AquaComfort PLUS, which releases moisture with every blink; and the monthly Air Optix family, including Air Optix plus HydraGlyde with SmartShield and HydraGlyde moisture matrix technologies.[P-30b060c2ef9a4f63938c0bae4b687c95][P-821c0b776b51437c88dd80cb2a077e06][P-a36e94431c814157873c18187774b174][P-ec54da6c2af149648b1e0a4504f10413] Its ocular-health products include the Systane artificial tear and dry-eye range, Pataday allergy eye drops, and Opti-Free and Clear Care lens-care solutions.[P-976d14d2b79d4cbc911240fd735205d6] In 2024, Surgical represented about 56.1% of net sales, while Vision Care represented about 43.9%; within Vision Care, contact lenses were about 26.5% of total net sales and ocular health about 17.3%.[T-da396ebbf02640b2b03df291dda35758]\n[P-cd41ce9d9526495f952db60ccde56bfc][P-094cdf2a5a16486c94dec8cd630fd277][P-4a918bdc6ce742099f9f774009a3b9a4][P-1f15f9af2aa2437ba7694297a8d7ad77][P-a9a0f600fbc142cc817f628021df983e][P-8440ef557ab847278f97f636bb58fdd0][P-22dcda6ecfb340edaaaaad778c0c4da6][P-9d2e22d6015945a28a5c740a4a75ce8c][P-30b060c2ef9a4f63938c0bae4b687c95][P-821c0b776b51437c88dd80cb2a077e06][P-a36e94431c814157873c18187774b174][P-ec54da6c2af149648b1e0a4504f10413][P-976d14d2b79d4cbc911240fd735205d6][T-da396ebbf02640b2b03df291dda35758]",
      "updatedAt": "2026-03-20T05:05:42.228234Z"
    },
    {
      "type": "GEOGRAPHY",
      "text": "Alcon has operations in 56 countries and sells its products in more than 140 countries. Its global footprint is supported by more than 3,900 direct-sales associates and 17 manufacturing facilities. The company’s corporate headquarters are in Geneva, Switzerland; its principal office for Swiss and international operations, which is also its registered office, is in Fribourg, Switzerland; and its principal U.S. office is in Fort Worth, Texas.[P-63e3f73028dd4e51885dd035685358d2][P-a30a3ae15de14f5cba309baf731a7896][P-2f5c588befdd44c3bdb474432e60620a]\n\nIn 2024, the United States generated $4.511 billion of net sales, or 46% of total net sales, while international markets generated $5.325 billion, or 54%, based on the location of the third-party customer. Among the specifically disclosed international countries, China contributed $560 million (6% of total net sales), Japan contributed $554 million (6%), and Switzerland contributed $79 million (1%), with all other international markets contributing $4.132 billion (42%). Selected non-current assets were split between the United States at $11.380 billion (51%) and international markets at $10.991 billion (49%); within that international base, Switzerland accounted for $8.800 billion, or 39% of total selected non-current assets.[P-5a5cefa22d354e38b46c6d65257f407a]\n\nThe company also lists major production and R&D locations across North America, Europe and Asia, including sites in Texas, Georgia, California, North Carolina, Pennsylvania and West Virginia in the United States; Germany, Ireland, Belgium and Switzerland in Europe; and Singapore, Malaysia and Indonesia in Asia.[T-2779211def024ebf9205061b1d323c31]\n[P-63e3f73028dd4e51885dd035685358d2][P-a30a3ae15de14f5cba309baf731a7896][P-2f5c588befdd44c3bdb474432e60620a][P-5a5cefa22d354e38b46c6d65257f407a][T-2779211def024ebf9205061b1d323c31]",
      "updatedAt": "2026-03-20T05:05:42.228234Z"
    },
    {
      "type": "SEGMENTS",
      "text": "Alcon reports two business segments: Surgical and Vision Care, which are the company’s official reportable segments and are managed separately because they have distinct research, development, manufacturing, distribution and commercial execution requirements [P-5e7df94e9006455197d72999fbd17e6a][P-97bfd029a99b4389b7d68d19684f4087]. Surgical focuses on ophthalmic products used in cataract, vitreoretinal, refractive laser and glaucoma surgery, and includes implantables, consumables and surgical equipment [P-cd41ce9d9526495f952db60ccde56bfc]. Vision Care comprises contact lenses and ocular health products, including products for dry eye, ocular allergies, glaucoma, contact lens care, ocular vitamins and redness relievers [P-cd41ce9d9526495f952db60ccde56bfc].\n\nBased on 2024 net sales, Surgical contributed approximately 56% of revenue ($5.522 billion of $9.836 billion), while Vision Care contributed about 44% ($4.314 billion) [T-1e62a4f9ac0345b1aba40cf1943f1951]. Within Surgical, the 2024 mix was approximately $1.775 billion from implantables, $2.861 billion from consumables and $0.886 billion from equipment/other [T-1e62a4f9ac0345b1aba40cf1943f1951]. Within Vision Care, the 2024 mix was approximately $2.609 billion from contact lenses and $1.705 billion from ocular health [T-1e62a4f9ac0345b1aba40cf1943f1951].\n[P-5e7df94e9006455197d72999fbd17e6a][P-97bfd029a99b4389b7d68d19684f4087][P-cd41ce9d9526495f952db60ccde56bfc][T-1e62a4f9ac0345b1aba40cf1943f1951]",
      "updatedAt": "2026-03-20T05:05:42.228234Z"
    },
    {
      "type": "HISTORY",
      "text": "Alcon traces its origins to 1945, when pharmacists Robert Alexander and William Conner opened a small pharmacy in Fort Worth, Texas under the Alcon name. The business was incorporated in 1947 and moved into manufacturing specialty pharmaceutical products for eye care, laying the foundation for its later ophthalmic focus.[P-77f2196a30cd4dc796403968d60bd81f]\n\nA major change in ownership came in 1977, when Alcon was acquired by a Swiss subsidiary of Nestlé S.A. Alcon remained a wholly owned Nestlé subsidiary until 2002, when Nestlé sold about 25% of the company in an initial public offering and Alcon began trading on the New York Stock Exchange.[P-febe01d39e7e4a048b2b8c88c4976871]\n\nFrom 2008 through 2011, Novartis acquired Alcon in a series of transactions and operated it as the Alcon division within Novartis.[P-febe01d39e7e4a048b2b8c88c4976871] On April 9, 2019, Novartis completed the legal and structural separation of Alcon through a spin-off, returning it to stand-alone status as an independent public company.[P-a747d7e2116e48b9972bea09178d4554]\n[P-77f2196a30cd4dc796403968d60bd81f][P-febe01d39e7e4a048b2b8c88c4976871][P-a747d7e2116e48b9972bea09178d4554]",
      "updatedAt": "2026-03-20T05:05:42.228234Z"
    }
  ],
  "sources": [
    {
      "id": "P-1a37f89c289c4989882dfce3105753c1",
      "href": "https://app.finbar.com/go?id=P-1a37f89c289c4989882dfce3105753c1",
      "label": "ALCON INC — Full financial report (2023 Y), p47",
      "documentId": "D-0d5164f362d1492196886d207d9ccf20",
      "page": 47
    },
    {
      "id": "P-01443116eca041228efb337fff6f2f86",
      "href": "https://app.finbar.com/go?id=P-01443116eca041228efb337fff6f2f86",
      "label": "ALCON INC — Full financial report (2023 Y), p55",
      "documentId": "D-0d5164f362d1492196886d207d9ccf20",
      "page": 55
    },
    {
      "id": "P-36209d85eb704cf0ab44a6c12aa614de",
      "href": "https://app.finbar.com/go?id=P-36209d85eb704cf0ab44a6c12aa614de",
      "label": "ALCON INC — Full financial report (2023 Y), p51",
      "documentId": "D-0d5164f362d1492196886d207d9ccf20",
      "page": 51
    },
    {
      "id": "P-e942a20bf9114acc94c97bcf8d4de1a3",
      "href": "https://app.finbar.com/go?id=P-e942a20bf9114acc94c97bcf8d4de1a3",
      "label": "ALCON INC — Full financial report (2023 Y), p51",
      "documentId": "D-0d5164f362d1492196886d207d9ccf20",
      "page": 51
    },
    {
      "id": "P-f9caf3f82a674ff0970db5207b84547f",
      "href": "https://app.finbar.com/go?id=P-f9caf3f82a674ff0970db5207b84547f",
      "label": "ALCON INC — Full financial report (2023 Y), p4",
      "documentId": "D-0d5164f362d1492196886d207d9ccf20",
      "page": 4
    },
    {
      "id": "P-85b96b3159244662b7b7721636f51f3d",
      "href": "https://app.finbar.com/go?id=P-85b96b3159244662b7b7721636f51f3d",
      "label": "ALCON INC — Full financial report (2023 Y), p8",
      "documentId": "D-0d5164f362d1492196886d207d9ccf20",
      "page": 8
    },
    {
      "id": "P-69e31f47af214e529c029b391f2f74be",
      "href": "https://app.finbar.com/go?id=P-69e31f47af214e529c029b391f2f74be",
      "label": "ALCON INC — Full financial report (2023 Y), p2",
      "documentId": "D-0d5164f362d1492196886d207d9ccf20",
      "page": 2
    },
    {
      "id": "P-532498a2b25647909bfcc688d79b2d02",
      "href": "https://app.finbar.com/go?id=P-532498a2b25647909bfcc688d79b2d02",
      "label": "ALCON INC — Full financial report (2023 Y), p52",
      "documentId": "D-0d5164f362d1492196886d207d9ccf20",
      "page": 52
    },
    {
      "id": "P-94fb4af7b9024e1bb5df7d9a1f3bbe86",
      "href": "https://app.finbar.com/go?id=P-94fb4af7b9024e1bb5df7d9a1f3bbe86",
      "label": "ALCON INC — Full financial report (2023 Y), p49",
      "documentId": "D-0d5164f362d1492196886d207d9ccf20",
      "page": 49
    },
    {
      "id": "P-cd41ce9d9526495f952db60ccde56bfc",
      "href": "https://app.finbar.com/go?id=P-cd41ce9d9526495f952db60ccde56bfc",
      "label": "ALCON INC — Full financial report (2024 Y), p42",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 42
    },
    {
      "id": "P-094cdf2a5a16486c94dec8cd630fd277",
      "href": "https://app.finbar.com/go?id=P-094cdf2a5a16486c94dec8cd630fd277",
      "label": "ALCON INC — Full financial report (2024 Y), p51",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 51
    },
    {
      "id": "P-4a918bdc6ce742099f9f774009a3b9a4",
      "href": "https://app.finbar.com/go?id=P-4a918bdc6ce742099f9f774009a3b9a4",
      "label": "ALCON INC — Full financial report (2024 Y), p51",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 51
    },
    {
      "id": "P-1f15f9af2aa2437ba7694297a8d7ad77",
      "href": "https://app.finbar.com/go?id=P-1f15f9af2aa2437ba7694297a8d7ad77",
      "label": "ALCON INC — Full financial report (2024 Y), p52",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 52
    },
    {
      "id": "P-a9a0f600fbc142cc817f628021df983e",
      "href": "https://app.finbar.com/go?id=P-a9a0f600fbc142cc817f628021df983e",
      "label": "ALCON INC — Full financial report (2024 Y), p53",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 53
    },
    {
      "id": "P-8440ef557ab847278f97f636bb58fdd0",
      "href": "https://app.finbar.com/go?id=P-8440ef557ab847278f97f636bb58fdd0",
      "label": "ALCON INC — Full financial report (2024 Y), p56",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 56
    },
    {
      "id": "P-22dcda6ecfb340edaaaaad778c0c4da6",
      "href": "https://app.finbar.com/go?id=P-22dcda6ecfb340edaaaaad778c0c4da6",
      "label": "ALCON INC — Full financial report (2024 Y), p52",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 52
    },
    {
      "id": "P-9d2e22d6015945a28a5c740a4a75ce8c",
      "href": "https://app.finbar.com/go?id=P-9d2e22d6015945a28a5c740a4a75ce8c",
      "label": "ALCON INC — Full financial report (2024 Y), p52",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 52
    },
    {
      "id": "P-30b060c2ef9a4f63938c0bae4b687c95",
      "href": "https://app.finbar.com/go?id=P-30b060c2ef9a4f63938c0bae4b687c95",
      "label": "ALCON INC — Full financial report (2024 Y), p54",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 54
    },
    {
      "id": "P-821c0b776b51437c88dd80cb2a077e06",
      "href": "https://app.finbar.com/go?id=P-821c0b776b51437c88dd80cb2a077e06",
      "label": "ALCON INC — Full financial report (2024 Y), p54",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 54
    },
    {
      "id": "P-a36e94431c814157873c18187774b174",
      "href": "https://app.finbar.com/go?id=P-a36e94431c814157873c18187774b174",
      "label": "ALCON INC — Full financial report (2024 Y), p55",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 55
    },
    {
      "id": "P-ec54da6c2af149648b1e0a4504f10413",
      "href": "https://app.finbar.com/go?id=P-ec54da6c2af149648b1e0a4504f10413",
      "label": "ALCON INC — Full financial report (2024 Y), p55",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 55
    },
    {
      "id": "P-976d14d2b79d4cbc911240fd735205d6",
      "href": "https://app.finbar.com/go?id=P-976d14d2b79d4cbc911240fd735205d6",
      "label": "ALCON INC — Full financial report (2024 Y), p55",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 55
    },
    {
      "id": "T-da396ebbf02640b2b03df291dda35758",
      "href": "https://app.finbar.com/go?id=T-da396ebbf02640b2b03df291dda35758",
      "label": "ALCON INC — Full financial report (2024 Y), p202",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 202
    },
    {
      "id": "P-63e3f73028dd4e51885dd035685358d2",
      "href": "https://app.finbar.com/go?id=P-63e3f73028dd4e51885dd035685358d2",
      "label": "ALCON INC — Full financial report (2024 Y), p46",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 46
    },
    {
      "id": "P-a30a3ae15de14f5cba309baf731a7896",
      "href": "https://app.finbar.com/go?id=P-a30a3ae15de14f5cba309baf731a7896",
      "label": "ALCON INC — Full financial report (2024 Y), p57",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 57
    },
    {
      "id": "P-2f5c588befdd44c3bdb474432e60620a",
      "href": "https://app.finbar.com/go?id=P-2f5c588befdd44c3bdb474432e60620a",
      "label": "ALCON INC — Full financial report (2024 Y), p63",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 63
    },
    {
      "id": "P-5a5cefa22d354e38b46c6d65257f407a",
      "href": "https://app.finbar.com/go?id=P-5a5cefa22d354e38b46c6d65257f407a",
      "label": "ALCON INC — Full financial report (2024 Y), p203",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 203
    },
    {
      "id": "T-2779211def024ebf9205061b1d323c31",
      "href": "https://app.finbar.com/go?id=T-2779211def024ebf9205061b1d323c31",
      "label": "ALCON INC — Full financial report (2024 Y), p64",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 64
    },
    {
      "id": "P-5e7df94e9006455197d72999fbd17e6a",
      "href": "https://app.finbar.com/go?id=P-5e7df94e9006455197d72999fbd17e6a",
      "label": "ALCON INC — Full financial report (2024 Y), p201",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 201
    },
    {
      "id": "P-97bfd029a99b4389b7d68d19684f4087",
      "href": "https://app.finbar.com/go?id=P-97bfd029a99b4389b7d68d19684f4087",
      "label": "ALCON INC — Full financial report (2024 Y), p201",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 201
    },
    {
      "id": "T-1e62a4f9ac0345b1aba40cf1943f1951",
      "href": "https://app.finbar.com/go?id=T-1e62a4f9ac0345b1aba40cf1943f1951",
      "label": "ALCON INC — Full financial report (2024 Y), p74",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 74
    },
    {
      "id": "P-77f2196a30cd4dc796403968d60bd81f",
      "href": "https://app.finbar.com/go?id=P-77f2196a30cd4dc796403968d60bd81f",
      "label": "ALCON INC — Full financial report (2024 Y), p40",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 40
    },
    {
      "id": "P-febe01d39e7e4a048b2b8c88c4976871",
      "href": "https://app.finbar.com/go?id=P-febe01d39e7e4a048b2b8c88c4976871",
      "label": "ALCON INC — Full financial report (2024 Y), p40",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 40
    },
    {
      "id": "P-a747d7e2116e48b9972bea09178d4554",
      "href": "https://app.finbar.com/go?id=P-a747d7e2116e48b9972bea09178d4554",
      "label": "ALCON INC — Full financial report (2024 Y), p40",
      "documentId": "D-924bb9ba3a244ca1bfbc617c0e601fdd",
      "page": 40
    }
  ]
}